해동피를 포함한 한약제제 HPL-01의 Dextran sodium sulfate 유도 궤양성 대장염 완화 효과
Anti-Colitic Effects of Herbal Medicine HPL-01 on Dextran Sulfate Sodium Induced Ulcerative Colitis in Rat
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
This study aimed to investigate the anti-inflammatory effects of herbal complex HPL-01 on dextran sodium sulfate(DSS) induced ulcerative colitis in rat. Adult male Sprague–Dawley rats were randomized and divided into six groups. Five groups, excluding the normal group, were orally administered orally HPL-01(50, 100, or 200 mg/kg) for 21 days, and acute colitis was induced during the last 7 days by 4% DSS in the drinking water. The HPL-01 administered DSS-treated rats exhibited significantly reduced colon macroscopic damage index and increased body weight and colonic length 7 days after DSS treatment. Additionally, these rats showed lower serum levels of the pro-inflammatory cytokines TNF-α and IL-6 than those treated only with DSS. HPL-01(100 or 200 mg/kg) also attenuated the DSS-induced increase in the number of white blood cells, granulocytes, and mid cells and improved intestinal damage. Taken together, these results suggest that HPL-01 is a promising anti-inflammatory agent that may be in the treatment of colitis.
Abstract
This study aimed to investigate the anti-inflammatory effects of herbal complex HPL-01 on dextran sodium sulfate(DSS) induced ulcerative colitis in rat. Adult male Sprague–Dawley rats were randomized and divided into six groups. Five groups, excluding the normal group, were orally administered orally HPL-01(50, 100, or 200 mg/kg) for 21 days, and acute colitis was induced during the last 7 days by 4% DSS in the drinking water. The HPL-01 administered DSS-treated rats exhibited significantly reduced colon macroscopic damage index and increased body weight and colonic length 7 days after DSS treatment. Additionally, these rats showed lower serum levels of the pro-inflammatory cytokines TNF-α and IL-6 than those treated only with DSS. HPL-01(100 or 200 mg/kg) also attenuated the DSS-induced increase in the number of white blood cells, granulocytes, and mid cells and improved intestinal damage. Taken together, these results suggest that HPL-01 is a promising anti-inflammatory agent that may be in the treatment of colitis.
참고문헌 (25)
- Sands, "From symptom to diagnosis : clinical distinctions among various forms of intestinal inflammation", Gastro, 126, pp.1518~1532 (2004)
- 남해인, "당귀 추출물의 궤양성 대장염 억제 효과에 대한 연구", 동의생리병리학회지, 30(6), pp.439~446 (2016), 한의병리학회[DOI]
- Blumberg RS, "Animal models of mucosal inflammation and their relation to human inflammatory bowel disease", Curr Opin Immunol, 11, pp.648~656 (1999)
- Jiminez JA, "Animal models to study acute and chronic intestinal inflammation in mammals", Gut Pathog, 7, pp.29~ (2015)
- Klotz U, "Colonic targeting of aminosalicylates for the treatment of ulcerative colitis", Dig Liver Dis, 37, pp.381~388 (2005)
- Hanauer SB, "Therapy of ulcerative colitis", Curr Opin Gastro, 20, pp.345~350 (2004)
- Hyun TK, "The pharmacology and clinical properties of Kalopanax pictus", J Med Plants Res, 3, pp.613~620 (2009)
- Choi J, "Antinociceptive and anti-rheumatoidal effects of Kalopanax pictus extract and its saponin components in experimental animals", J Ethnopharmacol, 79, pp.199~204 (2002)
- Hamauzu Y, "Gastroprotective property of Pseudocydonia sinensis fruit jelly on the ethanol-induced gastric lesions in rats", J Functional Foods, 48, pp.275~282 (2018)
- Sham TT, "A review of the phytochemistry and pharmacological activities of raphani semen", Evid.-Based Complementary Altern. Med, pp.636194~ (2013)
- 김창민, "백개자, 나복자 및 두 배합 약물의 천식 동물 모델에 대한 효과", 대한본초학회지, 28(6), pp.15~23 (2013), 대한본초학회
- 허인희, "창출 추출물의 BV2 cell 소염작용에 관한 실험적 연구", 한방안이비인후피부과학회지, 20(2), pp.36~46 (2007), 대한한방안이비인후피부과학회
- Lim DJ, "Induction of apoptotic cell death by ethanolic extract of aconiti tuber in human hepatocarcinoma cells", Cancer Prevent Res, 13(2), pp.142~152 (2008)
- McCafferty DM, "Beneficial effects of local or systemic lidocaine in experimental colitis", Am J Physiol Gastrointest Liver Physiol, 266, pp.G560~7 (1994)
- Akiyama S, "Effects of anthocyanin-rich tea"Sunrouge"on dextran sodium sulfate-induced colitis in mice", Biofactors, 38, pp.226~233 (2012)
- Marocchi M, "Cytokine Networks in Ulcerative Colitis", Ulcers, pp.391787~391795 (2011)
- Nakajima H, "Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine", J Gastroenterol, 30, pp.115~117 (1995)
- Schroeder KW, "Is mesalamine safe?", Gastroenterol Hepatol(N Y), 3, pp.878~879 (2007)
- Sands BE, "Inflammatory bowel disease : past, present, and future", J Gastroenterol, 42, pp.16~25 (2007)
- Baumgart DC, "Inflammatory bowel disease : cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)
- Kim HS, "Experimental colitis in animal models", Scand J gastroenterol, 27, pp.529~537 (1992)
- Ardizzone S, "Biologic therapy for inflammatory bowel disease", Drugs, 65, pp.2253~2286 (2005)
- Adegbola SO, "Anti-TNF Therapy in Crohn’s Disease", IJMS, 19, pp.2244~ (2018)
- Fiocchi C, "Inflammatory bowel disease : etiology and pathogenesis", Gastroenterol, 115, pp.182~205 (1998)
- Melgar S, "Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice", Stress, 11, pp.348~362 (2008)